Transfusion medicine handbook

[1]

A. Shah, V. Kerner, S. J. Stanworth and S. Agarwal, "Major haemorrhage: past, present and future," Anaesthesia, vol. 78, pp. 93-104, 2023.

[2]

S. J. Stanworth, K. Dowling, N. Curry, H. Doughty, B. J. Hunt, L. Fraser, S. Narayan, J. Smith, I. Sullivan and L. Green, "Haematological management of major haemorrhage: a British Society for Haematology Guideline," British Journal of Haematology, vol. 198, no. 4, pp. 654-667, 2022.

[3]

CRASH-2 trial collaborators, H. Shakur, I. Roberts, R. Bautista, J. Caballero, T. Coats, Y. Dewan, H. El-Sayed, T. Gogichaishivili, S. Gupta, J. Herrera, B. Hunt and et al, "Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial.," Lancet, vol. 376, no. 9734, pp. 23-32, 2010.

[4]

G. H. Ramesh, J. C. Uma and S. Farhath, "Fluid resuscitation in trauma: what are the best strategies and fluids?," International Journal of Emergency Medicine, vol. 12, no. 38, pp. https://doi.org/10.1186/s12245-019-0253-8, 2019.

[5]

European Medicines Agency, "Hydroxyethyl starch solutions: CMDh introduces new measures to protect patients," 17 July 2018. [Online]. Available: https://www.ema.europa.eu/en/documents/referral/hydroxyethyl-starch-article-107i-referral-hydroxyethyl-starch-solutions-cmdh-introduces-new-measures_en-0.pdf. [Accessed 08 March 2023].

[6]

H. A. Tran, S. D. Chunilal and H. Tran, "An update of consensus guidelines for warfarin reversal," The Medical Journal of Australia, vol. 198, no. 4, pp. 198-199, 2014.

[7]

H. A. Tran, J. E. Joseph, L. Young, S. McRae, J. Curnow, H. Nandurkar, P. Wood and C. K. McLintock, "New oral anticoagulants: a practical guide on prescription, laboratory testing and peri-procedural/bleeding management," Internal Medicine Journal, vol. 44, no. 6, pp. 525-536, 2014.

[8]

PHARMAC, "Guidelines for testing and perioperative," 2018. [Online]. Available: https://bpac.org.nz/2018/docs/dabigatran-rivaroxaban-testing-and-perioperative-management.pdf. [Accessed 27 October 2021].

[9]

Ministry of Health (New Zealand), "New Zealand Universal List of Medicines," 2021. [Online]. Available: https://info.nzulm.org.nz/. [Accessed 27 October 2021].

[10]

bpac, Pharmac, NZ Govt, "Guidelines for management of bleeding with dabigatran or rivaroxaban: for possible use in local management protocols," 2018. [Online]. Available: https://bpac.org.nz/2018/docs/dabigatran-rivaroxaban-bleeding-management.pdf. [Accessed 24 03 2023].

[11]

Australian & New Zealand Society of Blood Transfusion Ltd, "Guidelines for transfusion and immunohaematology laboratory practice," January 2020. [Online]. Available: https://anzsbt.org.au/wp-content/uploads/2021/04/Guideline_-for_Transfusion_and_Immunohaematology_Laboratory_Practice_FINAL_Published_20210426.pdf. [Accessed 30 August 2022].

[12]

RANZCOG, "Guidelines for the use of Rh(D) Immunoglobulin (Anti-D) in obstetrics," July 2019. [Online]. Available: https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Anti-D-guidelines_July-2021.pdf?ext=.pdf. [Accessed 29 October 2021].

[13]

National Institute for Health and Care Excellence (NICE), "Routine antenatal anti-D prophylaxis for women who are rhesus D negative," 27 August 2008. [Online]. Available: https://www.nice.org.uk/guidance/ta156/resources/routine-antenatal-antid-prophylaxis-for-women-who-are-rhesus-d-negative-pdf-82598318102725. [Accessed 31 October 2021].

[14]

National Institute for Health and Care Excellence (NICE), "NICE Guideline: Abortion care," 25 September 2019. [Online]. Available: https://www.nice.org.uk/guidance/ng140/resources/abortion-care-pdf-66141773098693. [Accessed 31 October 2021].

[15]

Australian Red Cross Blood Service/ National Blood Authority Australia, "Expert Panel Consensus Position Statement regarding the Use of Rh(D) Immunoglobulin in Patients with a Body Mass Index >30," 2015. [Online]. Available: https://ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Consensus-Position-Statement-RhDIg-and-Women-with-High-BMI.pdf?ext=.pdf. [Accessed 29 October 2021].

[16]

Sydney Local Health District, "Blood Product Transfusion in the Newborn," October 2016. [Online]. Available: https://www.slhd.nsw.gov.au/rpa/neonatal/content/pdf/guidelines/Neonatal_Transfusions_November_2016.pdf. [Accessed 31 October 2021].

[17]

Joint United Kingdom Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee, "10.2: Neonatal transfusion," Target Information Systems, 01 April 2020. [Online]. Available: https://www.transfusionguidelines.org/transfusion-handbook/10-effective-transfusion-in-paediatric-practice/10-2-neonatal-transfusion. [Accessed 31 10 2021].

[18]

H. V. New, J. Berryman, P. H. B. Bolton-Maggs, C. Cantwell, E. A. Chalmers, T. Davies, R. Gottstein, A. Kelleher, S. Kumar, S. L. Morley and S. J. Stanworth, "Guidelines on transfusion for fetuses, neonates and older children," British Journal of Haematology, vol. 175, no. 5, pp. 784-828, 2016.

[19]

H. V. New, S. J. Stanworth, R. Gottstein, C. Cantwell, J. Berryman, E. A. Chalmers, P. H. B. Bolton-Maggs and B. G. T. T. Force, "British Society for Haematology Guidelines on transfusion for fetuses, neonates and older children (Br J Haematol. 2016;175:784-828). Addendum August 2020.," British Journal of Haematology, vol. 191, no. 5, pp. 725-727, 2020.

[20]

T. Bakchoul, D. Bassler, M. Heckmann, T. Thiele, V. Kiefel, I. Gross, D. M. Arnold and e. al, "Management of infants born with severe neonatal alloimmune thrombocytopenia: the role of platelet transfusions and intravenous immunoglobulin.," Transfusion, vol. 54, no. 3, pp. 640-6, 2014.

[21]

L. Lieberman, A. Greinacher, M. F. Murphy, J. Bussel, T. Bakchoul, S. Corke, M. Kjaer and et al, "International Collaboration for Transfusion Medicine Guidelines (ICTMG). Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach.," Br J Haematol, vol. 185, no. 3, pp. 549-562, May 2019.